ACARIX AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.23 SEK | -1.08% |
|
-6.12% | +21.18% |
Presenter SpeechFilip Einarsson (Analysts)Welcome, everybody, to today's Live Q together with ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Companyâs primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Calendar
2024-05-13
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.18% | 16.62M | |
| -12.91% | 19.08B | |
| -46.21% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +23.78% | 1.21B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -7.14% | 716M | |
| -18.10% | 682M |
- Stock Market
- Equities
- ACARIX Stock
- News Acarix AB
- Transcript : Acarix AB, Q3 2023 Earnings Call, Nov 09, 2023
